XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.2
Supplemental Income Statement Information - Scheduleof Disaggregated Revenues (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Jun. 28, 2025
Jun. 29, 2024
Disaggregation of Revenue [Line Items]        
Total revenues $ 10,855 $ 10,541 $ 21,219 $ 20,886
Life Sciences Solutions        
Disaggregation of Revenue [Line Items]        
Total revenues 2,115 1,996 4,069 3,926
Analytical Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,669 1,727 3,346 3,356
Specialty Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 1,118 1,100 2,248 2,200
Laboratory Products and Biopharma Services        
Disaggregation of Revenue [Line Items]        
Total revenues 5,953 5,719 11,556 11,404
Total Reportable Segments        
Disaggregation of Revenue [Line Items]        
Total revenues 11,356 11,011 22,202 21,817
Total Reportable Segments | Life Sciences Solutions        
Disaggregation of Revenue [Line Items]        
Total revenues 2,499 2,355 4,840 4,640
Total Reportable Segments | Life Sciences Solutions | Biosciences        
Disaggregation of Revenue [Line Items]        
Total revenues 1,075 1,059 2,068 2,118
Total Reportable Segments | Life Sciences Solutions | Genetic sciences        
Disaggregation of Revenue [Line Items]        
Total revenues 679 663 1,356 1,300
Total Reportable Segments | Life Sciences Solutions | BioProduction        
Disaggregation of Revenue [Line Items]        
Total revenues 745 633 1,416 1,223
Total Reportable Segments | Analytical Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,728 1,782 3,446 3,469
Total Reportable Segments | Analytical Instruments | Chromatography and mass spectrometry        
Disaggregation of Revenue [Line Items]        
Total revenues 784 773 1,557 1,562
Total Reportable Segments | Analytical Instruments | Chemical analysis        
Disaggregation of Revenue [Line Items]        
Total revenues 292 324 578 644
Total Reportable Segments | Analytical Instruments | Electron microscopy        
Disaggregation of Revenue [Line Items]        
Total revenues 652 684 1,311 1,263
Total Reportable Segments | Specialty Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 1,134 1,117 2,282 2,227
Total Reportable Segments | Specialty Diagnostics | Clinical diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 276 273 539 536
Total Reportable Segments | Specialty Diagnostics | ImmunoDiagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 234 226 451 437
Total Reportable Segments | Specialty Diagnostics | Microbiology        
Disaggregation of Revenue [Line Items]        
Total revenues 159 158 311 312
Total Reportable Segments | Specialty Diagnostics | Transplant diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 124 111 237 217
Total Reportable Segments | Specialty Diagnostics | Healthcare market channel        
Disaggregation of Revenue [Line Items]        
Total revenues 407 411 880 849
Total Reportable Segments | Laboratory Products and Biopharma Services        
Disaggregation of Revenue [Line Items]        
Total revenues 5,995 5,758 11,635 11,480
Total Reportable Segments | Laboratory Products and Biopharma Services | Laboratory products        
Disaggregation of Revenue [Line Items]        
Total revenues 601 639 1,183 1,264
Total Reportable Segments | Laboratory Products and Biopharma Services | Research and safety market channel        
Disaggregation of Revenue [Line Items]        
Total revenues 1,883 1,775 3,610 3,486
Total Reportable Segments | Laboratory Products and Biopharma Services | Pharma services        
Disaggregation of Revenue [Line Items]        
Total revenues 1,794 1,627 3,401 3,205
Total Reportable Segments | Laboratory Products and Biopharma Services | Clinical research        
Disaggregation of Revenue [Line Items]        
Total revenues 1,955 1,949 3,894 3,982
Elimination of intersegment revenues        
Disaggregation of Revenue [Line Items]        
Total revenues (501) (470) (983) (930)
Elimination of intersegment revenues | Specialty Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues (65) (62) (137) (125)
Elimination of intersegment revenues | Laboratory Products and Biopharma Services        
Disaggregation of Revenue [Line Items]        
Total revenues (238) (233) (453) (457)
North America        
Disaggregation of Revenue [Line Items]        
Total revenues 5,722 5,529 11,235 11,048
Europe        
Disaggregation of Revenue [Line Items]        
Total revenues 2,830 2,663 5,454 5,282
Asia-Pacific        
Disaggregation of Revenue [Line Items]        
Total revenues 1,920 1,971 3,811 3,831
Other regions        
Disaggregation of Revenue [Line Items]        
Total revenues 383 379 720 725
Consumables        
Disaggregation of Revenue [Line Items]        
Total revenues 4,606 4,363 8,960 8,690
Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,644 1,800 3,270 3,428
Services        
Disaggregation of Revenue [Line Items]        
Total revenues $ 4,605 $ 4,378 $ 8,990 $ 8,768